Literature DB >> 12827115

Gamma-hydroxybutyrate serum levels and clinical syndrome after severe overdose.

Karl A Sporer1, Rachel L Chin, Jo Ellen Dyer, Ryan Lamb.   

Abstract

STUDY
OBJECTIVE: We discuss a prospective case series of patients who present with a severe gamma-hydroxybutyrate intoxication with confirmatory serum and urine gamma-hydroxybutyrate levels.
METHODS: Patients with a clinical suspicion of gamma-hydroxybutyrate-like drug overdoses and a Glasgow Coma Scale score of 8 or lower were identified from July 1998 through January 1999. Serial serum specimens and a single urine specimen were collected. The levels of gamma-hydroxybutyrate were performed by gas chromatography-mass spectrometry.
RESULTS: All 16 suspected severe gamma-hydroxybutyrate overdose patients had significant serum or urine levels of gamma-hydroxybutyrate. Serum levels ranged from 45 to 295 mg/L, with a median of 180 mg/L (interquartile range [IQR] 235 to 118 mg/L). Patients who developed a Glasgow Coma Scale score of 3 had serum levels that ranged from 72 to 300 mg/L, with a median of 193 mg/L (IQR 242 to 124 mg/L). The time of awakening ranged from 30 minutes to 190 minutes, with a median of 120 minutes (IQR 150 to 83 minutes). Quantitative serum gamma-hydroxybutyrate levels did not correlate with the degree of coma or the time to awakening. Urine levels ranged from 432 to 2,407 mg/L, with a median of 1,263 mg/L (IQR 1,550 to 796 mg/L). Mild transitory hypoventilation occurred in 5 of the 16 patients.
CONCLUSION: All of our patients with clinically suspected severe gamma-hydroxybutyrate overdose were confirmed to have significant serum and urine levels of exogenous gamma-hydroxybutyrate. They presented with severe coma that lasted 1 to 2 hours. Transient hypoventilation occurred in one third of these patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12827115     DOI: 10.1067/mem.2003.253

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  13 in total

1.  Trends in gamma-hydroxybutyrate (GHB) and related drug intoxication: 1999 to 2003.

Authors:  Ilene B Anderson; Susan Y Kim; Jo Ellen Dyer; Cindy B Burkhardt; Jayme C Iknoian; Michael J Walsh; Paul D Blanc
Journal:  Ann Emerg Med       Date:  2005-12-28       Impact factor: 5.721

2.  GHB urine concentrations after single-dose administration in humans.

Authors:  Christine Haller; Dung Thai; Peyton Jacob; Jo Ellen Dyer
Journal:  J Anal Toxicol       Date:  2006 Jul-Aug       Impact factor: 3.367

Review 3.  Alternative drugs of abuse.

Authors:  M E Sutter; J Chenoweth; T E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2014-02       Impact factor: 8.667

4.  γ-Hydroxybutyric Acid (GHB) Pharmacokinetics and Pharmacodynamics: Semi-Mechanistic and Physiologically Relevant PK/PD Model.

Authors:  Rutwij A Dave; Kristin E Follman; Marilyn E Morris
Journal:  AAPS J       Date:  2017-06-26       Impact factor: 4.009

5.  [Agitation and gamma-hydroxybutyrate].

Authors:  M Hardmeier; M Eichhorn; G Stoppe
Journal:  Nervenarzt       Date:  2006-09       Impact factor: 1.214

6.  Forensic toxicology findings in deaths involving gamma-hydroxybutyrate.

Authors:  Fredrik C Kugelberg; Anita Holmgren; Arne Eklund; Alan Wayne Jones
Journal:  Int J Legal Med       Date:  2008-12-02       Impact factor: 2.686

7.  Endogenous gamma-hydroxybutyric acid (GHB) concentrations in post-mortem specimens and further recommendation for interpretative cut-offs.

Authors:  Hilke Andresen-Streichert; P Jensen; J Kietzerow; M Schrot; N Wilke; E Vettorazzi; A Mueller; S Iwersen-Bergmann
Journal:  Int J Legal Med       Date:  2014-08-02       Impact factor: 2.686

Review 8.  Overview of the proton-coupled MCT (SLC16A) family of transporters: characterization, function and role in the transport of the drug of abuse gamma-hydroxybutyric acid.

Authors:  Marilyn E Morris; Melanie A Felmlee
Journal:  AAPS J       Date:  2008-06-04       Impact factor: 4.009

9.  Experiences of gamma hydroxybutyrate (GHB) ingestion: a focus group study.

Authors:  Judith C Barker; Shana L Harris; Jo E Dyer
Journal:  J Psychoactive Drugs       Date:  2007-06

10.  γ-Hydroxybutyrate (GHB)-induced respiratory depression: combined receptor-transporter inhibition therapy for treatment in GHB overdose.

Authors:  Bridget L Morse; Nisha Vijay; Marilyn E Morris
Journal:  Mol Pharmacol       Date:  2012-05-04       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.